Wyeth Phasing Out New York Plant, Exploring Possible Sale

Drug Industry Daily
KEYWORDS Markets
A A

Wyeth plans to phase out its Rouses Point, N.Y., manufacturing operation over the next three years — a move prompted by slumping sales of the company’s hormone-replacement drug Premarin, which is made at the plant.

To View This Article:

Login

Subscribe To Drug Industry Daily